BRCA1 sequence analysis in women at high risk for susceptibility mutations: Risk factor analysis and implications for genetic testing

JAMA

Volumn 278, Issue 15, 1997, Pages 1242-1250

  Shattuck Eidens, Donna ^b   Oliphant, Arnold ^b   McClure, Melody ^b   McBride, Celeste ^b   Gupte, Jamila ^b   Rubano, Todd ^b   Pruss, Dmitry ^b   Tavtigian, Sean V ^b   Teng, David H F ^b   Adey, Nils ^b   Staebell, Mark ^b   Gumpper, Kathryn ^b   Lundstrom, Ron ^b   Hulick, Mark ^b   Kelly, Mark ^b   Holmen, John ^b   Lingenfelter, Beth ^b   Manley, Susan ^b   Fujimura, Frank ^b   Luce, Michael ^b   Ward, Brian ^b   Cannon Albright, Lisa ^b   Steele, Linda ^b   Offit, Kenneth ^b   Gilewski, Teresa ^b   Norton, Larry ^b   Brown, Karen ^b   Schulz, Charlene ^b   Hampel, Heather ^b   Schluger, Alice ^b   Giulotto, Elena ^b   Zoli, Wainer ^b   Ravaioli, Alberto ^b   Nevanlinna, Heli ^b   Pyrhonen, Seppo ^b   Rowley, Peter ^b   Loader, Starlene ^b   Osborne, Michael P ^b   Daly, Mary ^b   Tepler, Isidore ^b   Weinstein, Paul L ^b   Scalia, Jennifer L ^b   Michaelson, Richard ^b   Scott, Rodney J ^b   Radice, Paolo ^b   Pierotti, Marco A ^b   Garber, Judy E ^b   Isaacs, Claudine ^b   Peshkin, Beth ^b   Lippman, Marc E ^b   Dosik, Michael H ^b   Caligo, Maria A ^b   Greenstein, Robert M ^b   Pilarski, Robert ^b   Weber, Barbara ^b   Burgemeister, Renate ^b   Frank, Thomas S ^b   Skolnick, Mark H ^b   Thomas, Alun ^a   more..

^a Myriad Genetic Laboratories   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; ETHNOLOGY; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; RISK FACTOR; SEQUENCE ANALYSIS;

EID: 0030852505     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.278.15.1242     Document Type: Article

References (29)

1. Cancer Facts and Figures 1997. Atlanta, Ga: American Cancer Society; 1997.
2. Claus EB, Schildkraut JM, Thompson WD, Risch NJ. The genetic attributable risk of breast and ovarian cancer. Cancer. 1996;77:2318-2324.
3. Ford DF, Easton DF, Bishop DT, Narod SA, Goldgar DE. Risks of cancer in BRCA1-mutation carriers. Lancet. 1994;343:692-695.
4. Struewing JP, Hartge P, Wacholder S, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med. 1997;336:1401-1407.
5. Thorlacius S, Olafsdottir G, Tryggvadottir L, et al. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat Genet. 1996;13:117-119.
6. Phelan CM, Lancaster LM, Tonin P, et al. Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families. Nat Genet. 1996;13:120-122.
7. Tonin P, Weber B, Offit K, et al. Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat Med. 1996; 2:1179-1183.
8. Roa BB, Boyd AA, Volick K, Richards CS. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet. 1996; 14:185-187.
9. Oddoux C, Struewing JP, Clayton CM, et al. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nat Genet. 1996;14:188-190.
10. Tavtigian SV, Oliphant A, Shattuck-Eidens D, et al. Genomic organization, functional analysis, and mutation screening of BRCA1 and BRCA2. In: Fortner JG, Sharp PA, eds. General Motors Cancer Research Foundation Accomplishments in Cancer Research 1996. New York, NY: Lippincott-Raven; 1997.
11. Barker DF, Liu X, Almeida ER. The BRCA1 and 1A1.3B promoters are parallel elements of a genomic duplication at 17q21. Genomics. 1996;38: 215-222.
12. Brown MA, Xu C-F, Nicolai H, et al. The 5′ end of the BRCA1 gene lies within a duplicated region of human chromosome 17q21. Oncogene. 1996;12:2507-2513.
13. Serova O, Montagna M, Torchard D, et al. A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families. Am J Hum Genet. 1996;58: 42-51.
14. Beaudet AL, Tsui LC. A suggested nomenclature for designating mutations. Hum Mut. 1993;2: 245-248.
15. Berman DB, Wagner-Costalas J, Schultz DC, Lynch HT, Daly M, Godwin AK. Two distinct origins of a common BRCA1 mutation in breast-ovarian cancer families: a genetic study of 15 185delAG-mutation kindreds. Am J Hum Genet. 1996;58:1166-1176.
16. Langston AA, Malone KE, Thompson JD, Daling JR, Ostrander EA. BRCA1 mutations in a population-based sample of young women with breast cancer. N Engl J Med. 1996;334:137-142.
17. Statement of the American Society of Human Genetics on genetic testing for breast and ovarian cancer predisposition. Am J Hum Genet. 1994;55:i-iv.
18. Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility. J Clin Oncol. 1996;14:1730-1736.
19. Plummer SJ, Anton-Culver H, Webster L, et al. Detection of BRCA1 mutations by the protein truncation test. Hum Mol Genet. 1995;4:1989-1991.
20. Hogervorst FB, Cornelis RS, Bout M, et al. Rapid detection of BRCA1 mutations by the protein truncation test. Nat Genet. 1995;10:208-212.
21. Couch FJ, Weber BL, and the Breast Cancer Information Core. Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene. Hum Mut. 1996;8:8-18.
22. Durocher F, Shattuck-Eidens D, McClure M, et al. Comparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populations. Hum Mol Genet. 1996;5:835-842.
23. Barker DF, Almeida ER, Casey G, et al. BRCA1 R841W: a strong candidate for a common mutation with moderate phenotype. Genet Epidemiol. 1996; 13:595-604.
24. Miki Y, Swenson J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene, BRCA1. Science. 1994;266:66-71.
25. Koonin EV, Altschul SF, Bork P. BRCA1 protein products . . . functional motifs . . . Nat Genet. 1996;13:266-268.
26. Wu LC, Wang ZW, Tsan JT, et al. Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nat Genet. 1996;14:430-440.
27. Chen C-F, Li S, Chen Y, et al. The nuclear localization sequences of the BRCA1 protein interact with the importin-α subunit of the nuclear transport signal receptor. J Biol Chem. 1996;71:32863-32868.
28. Puget N, Torchard D, Serova-Sinilnikova OM, et al. A 1-kb Alu-mediated germ-line deletion removing BRCA1 exon 17. Cancer Res. 1997;57:828-831.
29. Couch FJ, DeShano ML, Blackwood MA, et al. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med. 1997;336:1409-1415.